These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors. Alemany R; Olmos G; García-Sevilla JA Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544 [TBL] [Abstract][Full Text] [Related]
6. Clorgyline. A new treatment for patients with refractory rapid-cycling disorder. Potter WZ; Murphy DL; Wehr TA; Linnoila M; Goodwin FK Arch Gen Psychiatry; 1982 May; 39(5):505-10. PubMed ID: 6807254 [TBL] [Abstract][Full Text] [Related]
7. Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia. Gutkind JS; Enero MA Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):189-92. PubMed ID: 6493360 [TBL] [Abstract][Full Text] [Related]
8. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain. Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528 [TBL] [Abstract][Full Text] [Related]
9. The induction of mania. A natural history study with controls. Lewis JL; Winokur G Arch Gen Psychiatry; 1982 Mar; 39(3):303-6. PubMed ID: 6121544 [TBL] [Abstract][Full Text] [Related]
10. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Wooters TE; Bardo MT Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044 [TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose clorgyline on 24-hour urinary monoamine excretion in patients with rapidly cycling bipolar affective disorder. Linnoila M; Karoum F; Potter WZ Arch Gen Psychiatry; 1982 May; 39(5):513-6. PubMed ID: 6178382 [TBL] [Abstract][Full Text] [Related]
12. Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents. McGrath PJ; Stewart JW; Tricamo E; Nunes EN; Quitkin FM J Clin Psychopharmacol; 1993 Jun; 13(3):224-5. PubMed ID: 8354742 [No Abstract] [Full Text] [Related]
13. Mania associated with high percentage of inhibition of monoamine oxidase. Bowden CL; Seleshi E; Javors MA Am J Psychiatry; 1989 Jan; 146(1):121. PubMed ID: 2912232 [No Abstract] [Full Text] [Related]
14. Common side effects associated with monoamine oxidase inhibitors. Remick RA; Froese C; Keller FD Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):497-504. PubMed ID: 2748873 [TBL] [Abstract][Full Text] [Related]
15. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo. Raft D; Davidson J; Wasik J; Mattox A Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477 [TBL] [Abstract][Full Text] [Related]
18. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors. Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930 [TBL] [Abstract][Full Text] [Related]
19. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298 [TBL] [Abstract][Full Text] [Related]
20. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression]. Nolen WA Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]